-
Mashup Score: 6Creating a Culture of Holistic Care in Lupus | GSK US - 11 day(s) ago
Lupus is a disease that flares and damages vital organs, GSK aims to improve lives through holistic care and a culture of health.
Source: us.gsk.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 4Home | GSK - 26 day(s) ago
At GSK, we unite science, technology and talent to get ahead of disease together
Source: www.gsk.comCategories: General Medicine News, PayerTweet-
RT @GSK: News for #Investors and #Media Explore our full year 2023 figures at a glance. Dive into the data: https://t.co/iq6ccrYH5Q. $GSK…
-
-
Mashup Score: 2Respiratory/ immunology | GSK - 1 month(s) ago
We are advancing the frontiers of respiratory science and leveraging our understanding of the immune system to transform patient outcomes.
Source: www.gsk.comCategories: General Medicine News, PayerTweet-
We’re excited to be at @ASNKidney week. As long-standing leaders in the #lupus community, we know how critical disease management is to try to help reduce organ damage progression for patients. Learn more: https://t.co/eFwdkoCHQ5 #KidneyWk https://t.co/DPHXzRIvl3
-
-
Mashup Score: 11GSK invests up to $800 million in Pennsylvania site, largest manufacturing investment in U.S. | GSK US - 1 month(s) ago
GSK is outfitting its Marietta, Pennsylvania, site with new state-of-the-art facilities dedicated to producing medicines and vaccines.
Source: us.gsk.comCategories: General Medicine News, PayerTweet-
We’re proud to be investing in US manufacturing to bring products and innovation to patients faster. Thanks to @GovernorShapiro, @DCEDSecretary, @SenatorAument and PA Rep Tom Jones for helping to make our Marietta Pennsylvania site expansion possible! https://t.co/vjpnOWTlc6 https://t.co/ID2nQInPNX
-
-
Mashup Score: 11GSK invests up to $800 million in Pennsylvania site, largest manufacturing investment in U.S. | GSK US - 1 month(s) ago
GSK is outfitting its Marietta, Pennsylvania, site with new state-of-the-art facilities dedicated to producing medicines and vaccines.
Source: us.gsk.comCategories: General Medicine News, PayerTweet-
Breaking #News: We are making our largest US manufacturing investment to date: $800 million in our Pennsylvania site, able to manufacture both medicines and vaccines, double the size of the site and over 200 new jobs. Read more here: https://t.co/WsiKOrp6Mx https://t.co/0xIjRIzwkx
-
-
Mashup Score: 0
Single dose of vaccine elicited robust immune response with acceptable safety profile in adults aged 18-49 at increased risk for RSV-LRTD.
Source: us.gsk.comCategories: General Medicine News, PayerTweet-
#News for #Investors and #Media: Today we shared data on our RSV vaccine. Learn more: https://t.co/eWswjH425L https://t.co/ce8HwWtvDC
-
-
Mashup Score: 0Infectious diseases | GSK - 1 month(s) ago
Our infectious disease portfolio is one of the broadest in the industry, and includes vaccines, antibiotics, antivirals and anti-fungals.
Source: www.gsk.comCategories: General Medicine News, PayerTweet-
Thanks for joining us at #IDWeek2024, where we’ve been sharing scientific advances from our industry-leading, prevention-focused portfolio of infectious disease vaccines and medicines. 🔗 Find out more: https://t.co/qOYDNKvjbo 👈 https://t.co/Lve90N5awb
-
-
Mashup Score: 0Infectious diseases | GSK - 1 month(s) ago
Our infectious disease portfolio is one of the broadest in the industry, and includes vaccines, antibiotics, antivirals and anti-fungals.
Source: www.gsk.comCategories: General Medicine News, PayerTweet-
We are excited to be at #IDWeek2024 to present research from across our broad and growing portfolio of vaccines and medicines aimed at getting ahead of infectious diseases. 🔗 Learn how are we developing new ways to prevent and treat infectious diseases: https://t.co/vjzT8e5O2i https://t.co/8ttHoo7dSH
-
-
Mashup Score: 0Infectious diseases | GSK - 1 month(s) ago
Our infectious disease portfolio is one of the broadest in the industry, and includes vaccines, antibiotics, antivirals and anti-fungals.
Source: www.gsk.comCategories: General Medicine News, PayerTweet-
Are you attending #IDWeek2024? So are we! Join us as we convene with global experts, sharing the latest advancements in the prevention and treatment of infectious diseases. 🔗 Learn more: https://t.co/U2gzuostqu
-
-
Mashup Score: 0GSK and ViiV Healthcare to showcase advances across industry-leading infectious disease portfolio at IDWeek 2024 | GSK US - 2 month(s) ago
60 abstracts to be presented across broad and growing portfolio of vaccines and medicines aimed at getting ahead of infectious disease.
Source: us.gsk.comCategories: General Medicine News, PayerTweet-
News for #Media and #Investors: Together with @ViiVHC, we’re presenting 60 abstracts to showcase advances across our industry-leading infectious disease pipeline and portfolio at #IDWeek2024. 🔗 Learn more: https://t.co/71aWD8UPQr
-
Social factors can majorly impact a person’s health, especially for people from racial & ethnic minority groups living with #lupus. GSK is addressing these challenges & encouraging early intervention for those living with this condition: https://t.co/WfEM50i2Nv @ACRheum #ACR24 https://t.co/sirV5ETTZV